{
    "organizations": [],
    "uuid": "e78f87b82c1067703058546b97aac5dd4ff7358f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shenzhen-hepalink-pharmaceuticals/brief-shenzhen-hepalink-pharmaceuticals-prelim-2017-net-profit-down-52-6-pct-y-y-idUSH9N1QB000",
    "ord_in_thread": 0,
    "title": "BRIEF-Shenzhen Hepalink Pharmaceutical's Prelim 2017 Net Profit Down 52.6 Pct Y/Y",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 26 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd :\n* SAYS PRELIM 2017 NET PROFIT DOWN 52.6 PERCENT Y/Y AT 188.0 MILLION YUAN ($29.81 million) Source text in Chinese: bit.ly/2F3uBJM Further company coverage: ($1 = 6.3057 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-02-26T17:42:00.000+02:00",
    "crawled": "2018-02-27T14:50:57.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "shenzhen",
        "hepalink",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "prelim",
        "net",
        "profit",
        "percent",
        "million",
        "yuan",
        "million",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}